Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences
- 18 April 2003
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 6 (3) , 111-127
- https://doi.org/10.1016/s1368-7646(03)00026-8
Abstract
No abstract availableKeywords
This publication has 151 references indexed in Scilit:
- What went wrong with Iressa?The Lancet Oncology, 2002
- MDR1 inhibition: less resistance or less relevance?European Journal Of Cancer, 2002
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunitOncogene, 2002
- Hyaluronidase reduces human breast cancer xenografts in SCID miceInternational Journal of Cancer, 2002
- Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectivesDrug Resistance Updates, 2001
- Anoikis mechanismsCurrent Opinion in Cell Biology, 2001
- Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cellsOncogene, 2001
- Mitochondria as targets for established and novel anti-cancer agentsDrug Resistance Updates, 2001
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996